Thalamic nuclei changes in early and late onset Alzheimer's disease
- PMID: 37397807
- PMCID: PMC10313877
- DOI: 10.1016/j.crneur.2023.100084
Thalamic nuclei changes in early and late onset Alzheimer's disease
Abstract
Alzheimer's disease (AD) is the most common cause of dementia worldwide. Increasing evidence points to the thalamus as an important hub in the clinical symptomatology of the disease, with the 'limbic thalamus' been described as especially vulnerable. In this work, we examined thalamic atrophy in early-onset AD (EOAD) and late-onset AD (LOAD) compared to young and old healthy controls (YHC and OHC, respectively) using a recently developed cutting-edge thalamic nuclei segmentation method. A deep learning variant of Thalamus Optimized Multi Atlas Segmentation (THOMAS) was used to parcellate 11 thalamic nuclei per hemisphere from T1-weighted MRI in 88 biomarker-confirmed AD patients (49 EOAD and 39 LOAD) and 58 healthy controls (41 YHC and 17 OHC) with normal AD biomarkers. Nuclei volumes were compared among groups using MANCOVA. Further, Pearson's correlation coefficient was computed between thalamic nuclear volume and cortical-subcortical regions, CSF tau levels, and neuropsychological scores. The results showed widespread thalamic nuclei atrophy in EOAD and LOAD compared to their respective healthy control groups, with EOAD showing additional atrophy in the centromedian and ventral lateral posterior nuclei compared to YHC. In EOAD, increased thalamic nuclei atrophy was associated with posterior parietal atrophy and worse visuospatial abilities, while LOAD thalamic nuclei atrophy was preferentially associated with medial temporal atrophy and worse episodic memory and executive function. Our findings suggest that thalamic nuclei may be differentially affected in AD according to the age at symptoms onset, associated with specific cortical-subcortical regions, CSF total tau and cognition.
Keywords: Early onset Alzheimer's disease; Late onset Alzheimer's disease; THOMAS-DL; Thalamic nuclei; Thalamus.
© 2023 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Albert Llado reports financial support was provided by 10.13039/501100004587Carlos III Health Institute. Mircea Balasa reports financial support was provided by 10.13039/501100004587Carlos III Health Institute. Michael Hornberger reports financial support was provided by Alzheimer's Research UK, Wellcome Trust. Neus Falgas reports financial support was provided by 10.13039/501100004587Carlos III Health Institute. Nuria Guillen reports financial support was provided by 10.13039/501100004587Carlos III Health Institute.
Figures




Similar articles
-
The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.Eur J Neurol. 2023 Mar;30(3):597-605. doi: 10.1111/ene.15657. Epub 2022 Dec 20. Eur J Neurol. 2023. PMID: 36463489 Free PMC article.
-
Structural Changes in Thalamic Nuclei Across Prodromal and Clinical Alzheimer's Disease.J Alzheimers Dis. 2021;82(1):361-371. doi: 10.3233/JAD-201583. J Alzheimers Dis. 2021. PMID: 34024824
-
Association of Subcortical Structural Shapes With Tau, Amyloid, and Cortical Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.Front Aging Neurosci. 2020 Oct 26;12:563559. doi: 10.3389/fnagi.2020.563559. eCollection 2020. Front Aging Neurosci. 2020. PMID: 33192457 Free PMC article.
-
Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit.Brain. 2016 Jul;139(Pt 7):1877-90. doi: 10.1093/brain/aww083. Epub 2016 Apr 28. Brain. 2016. PMID: 27190025 Free PMC article. Review.
-
Hierarchical Distribution of the Tau Cytoskeletal Pathology in the Thalamus of Alzheimer's Disease Patients.J Alzheimers Dis. 2016;49(4):905-15. doi: 10.3233/JAD-150639. J Alzheimers Dis. 2016. PMID: 26519431 Review.
Cited by
-
The effects of amyloidosis and aging on glutamatergic and GABAergic synapses, and interneurons in the barrel cortex and non-neocortical brain regions.Front Neuroanat. 2025 Feb 12;19:1526962. doi: 10.3389/fnana.2025.1526962. eCollection 2025. Front Neuroanat. 2025. PMID: 40012738 Free PMC article.
-
Automated brain segmentation and volumetry in dementia diagnostics: a narrative review with emphasis on FreeSurfer.Front Aging Neurosci. 2024 Sep 3;16:1459652. doi: 10.3389/fnagi.2024.1459652. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39291276 Free PMC article. Review.
-
A roadmap towards standardized neuroimaging approaches for human thalamic nuclei.Nat Rev Neurosci. 2024 Dec;25(12):792-808. doi: 10.1038/s41583-024-00867-1. Epub 2024 Oct 17. Nat Rev Neurosci. 2024. PMID: 39420114 Review.
-
Thalamic nuclei segmentation from T1-weighted MRI: Unifying and benchmarking state-of-the-art methods.Imaging Neurosci (Camb). 2024 May 8;2:1-16. doi: 10.1162/imag_a_00166. eCollection 2024 May 1. Imaging Neurosci (Camb). 2024. PMID: 40041300 Free PMC article.
-
Evaluating the effective segmentation of human lateral geniculate nucleus.Brain Struct Funct. 2025 Aug 25;230(7):140. doi: 10.1007/s00429-025-03000-9. Brain Struct Funct. 2025. PMID: 40853493
References
-
- Antonell A., Tort-Merino A., Rios J., Balasa M., Borrego-Ecija S., Auge J.M., Munoz-Garcia C., Bosch B., Falgas N., Rami L., Ramos-Campoy O., Blennow K., Zetterberg H., Molinuevo J.L., Llado A., Sanchez-Valle R. Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias. Alzheimers Dement. 2020;16(2):262–272. doi: 10.1016/j.jalz.2019.09.001. Feb. - DOI - PubMed
LinkOut - more resources
Full Text Sources